Mission:  promote ovarian cancer awareness and education; support those diagnosed and survivors; and advocate for public policy and funding.

Tumor Profiling & Treatment Presentation

  • 18 May 2021
  • 5:00 PM - 6:15 PM
  • Zoom Audio/Video

Registration is closed

Tumor Profiling & Treatment Presentation

May 18, 5pm-6:15pm

Zoom Audio/Video (Login Information in Registration Confirmation)

Did you know that the genetic makeup of your tumor may influence the way your doctor treats your ovarian cancer?

Some tumors are genetically disposed to accumulate more errors than others, and that treating these types of tumors with a new class of drugs called PARP inhibitors may significantly reduce the cancers progression.

Please join us to learn more about how genetics and PARP inhibitors are being used to help patients.

There will be a Q&A segment after the presentation.

About the Presenters:

Dr. Sharyn N. Lewin, Medical Director, Division of Gynecologic Oncology, Holy Name Medical Center

Diana Turco, MS, CGC, Medical Science Liaison, Myriad Labs, myChoice CDx, EndoPredict, and Companion Diagnostics

Please note: login information will be included in event registration confirmation and event reminder emails. We are unable to monitor emails for login information during live events.

Log in

Ovarian Cancer Alliance of Oregon and Southwest Washington
16420 SE McGillivray, Suite 103, PMB 243  
Vancouver, WA 98683-3461
(877) 682-2679        info@ovariancancerosw.org

We are a registered 501(c)(3) Non-Proft Corporation. EIN: 20-2558493
Copyright © 2005-2019 Ovarian Cancer Alliance of Oregon and Southwest Washington. All rights reserved.

Powered by Wild Apricot Membership Software